Compare ADAM & TRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADAM | TRNS |
|---|---|---|
| Founded | 2003 | 1964 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Electrical Products |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 826.7M | 799.0M |
| IPO Year | 2003 | 1995 |
| Metric | ADAM | TRNS |
|---|---|---|
| Price | $8.43 | $89.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $9.17 | ★ $116.00 |
| AVG Volume (30 Days) | ★ 921.1K | 69.9K |
| Earning Date | 04-29-2026 | 05-18-2026 |
| Dividend Yield | ★ 11.87% | N/A |
| EPS Growth | ★ 196.49 | N/A |
| EPS | ★ 0.87 | 0.14 |
| Revenue | N/A | ★ $331,877,000.00 |
| Revenue This Year | N/A | $21.75 |
| Revenue Next Year | $5.08 | $7.55 |
| P/E Ratio | ★ $10.11 | $655.93 |
| Revenue Growth | N/A | ★ 19.20 |
| 52 Week Low | $6.45 | $50.23 |
| 52 Week High | $10.36 | $100.00 |
| Indicator | ADAM | TRNS |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 60.17 |
| Support Level | N/A | $85.90 |
| Resistance Level | N/A | $94.58 |
| Average True Range (ATR) | 0.00 | 2.83 |
| MACD | 0.00 | 1.00 |
| Stochastic Oscillator | 0.00 | 94.45 |
Adamas Trust Inc is an internally-managed REIT for U.S. federal income tax purposes, in the business of acquiring, investing in, financing, and managing mainly mortgage-related single-family and multi-family residential assets. Its objective is to deliver long-term stable distributions to its stockholders over changing economic conditions through a combination of net interest spread and capital gains from a diversified investment portfolio. The company's investment portfolio includes credit-sensitive single-family and multi-family assets.
Transcat Inc is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing services and products to high regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical devices, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. It conducts business through two operating segments: Services and Distribution.